Phar 7.15(2)(2) A link to the 100 most commonly prescribed generic drug product equivalents as determined by the board, shall be maintained on the department’s website as required in s. 450.13 (5m) (b), Stats. Phar 7.15 NoteNote: Copies of the required consumer disclosures are located on the Department of Safety and Professional Service’s website: https://dsps.wi.gov. Phar 7.15(3)(3) Pursuant to s. 450.13 (5m) (c), Stats., each pharmacy shall maintain and make available to the public a list of the drugs from the list in sub. (2) that are available for purchase at that pharmacy. The list shall be updated monthly, with all of the following information included: Phar 7.15(4)(4) The list required under sub. (3) may differ depending on whether the drugs on the list from sub. (2) are available for purchase at a specific pharmacy. Phar 7.15 HistoryHistory: CR 23-015: cr. Register April 2024 No. 820, eff. 5-1-24; correction in (2) made under s. 35.17, Stats., Register April 2024 No. 820. Phar 7.30Phar 7.30 Definitions. In this subchapter: Phar 7.30(1)(1) “Central shared services pharmacy” means a pharmacy licensed in this state acting as an agent of an originating pharmacy. Phar 7.30(2)(2) “Labeling pharmacy” means the central shared services pharmacy or originating pharmacy which is responsible for product verification under s. Phar 7.07 (1) (a) and (b). Phar 7.30(3)(3) “Originating pharmacy” means a pharmacy licensed in this state that uses a central shared services pharmacy. Phar 7.30 HistoryHistory: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21. Phar 7.31Phar 7.31 Requirements. An originating pharmacy may use a central shared services pharmacy only pursuant to the following requirements: Phar 7.31(1)(1) The central shared services pharmacy either has the same owner as the originating pharmacy or has a written contract with the originating pharmacy outlining the services to be provided and the responsibilities of each pharmacy in fulfilling the terms of the contract. Phar 7.31(2)(2) The central shared services pharmacy shall maintain a record of all originating pharmacies, including name, address and DEA number that it provides services to. Phar 7.31(3)(3) The central shared services pharmacy and originating pharmacy maintain a written protocol delineating each pharmacy’s assumption of responsibility for compliance with state and federal law. Phar 7.31(4)(4) Unless the central shared services pharmacy shares a computer system with the originating pharmacy meeting the requirements of s. Phar 7.04 (4) and contains the medication profile record under s. Phar 7.11 (3), it may not perform drug utilization review under s. Phar 7.03 to satisfy the final check requirement under s. Phar 7.07 (1) (c). Phar 7.31(5)(5) The prescription label attached to the container shall contain the name and address of the labeling or originating pharmacy. The date on which the prescription was dispensed for purposes of s. 450.11 (4) (a) 2., Stats., shall be the date on which the labeling pharmacy filled the prescription order. Phar 7.31(6)(6) The originating pharmacy or central shared services pharmacy shall maintain the original of all prescription orders received for purposes of filing and recordkeeping as required by state and federal law. Phar 7.31(7)(7) In addition to meeting the other recordkeeping requirements required by state and federal law, the central shared services pharmacy and originating pharmacy shall each maintain records to identify each of its pharmacists responsible for the final check under s. Phar 7.07 (1). Phar 7.31 HistoryHistory: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21. Phar 7.40Phar 7.40 Definitions. In this subchapter: Phar 7.40(1)(1) “Delivery system” means a structure, controlled by a pharmacy licensed in this state, that a prescription is placed in for patient pick-up. Phar 7.40(2)(2) “Supervising pharmacy” means a licensed pharmacy that oversees the operations and administration of remote dispensing. Phar 7.40 HistoryHistory: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21; correction in (title) made under s. 13.92 (4) (b) 2., Stats., Register December 2020 No. 780. Phar 7.41(1)(1) A prescription shall be stored in a secure delivery system immediately upon delivery to the location of the delivery system. Only the patient or patient’s agent shall be able to open the door or locker containing only the patient’s prescription. Phar 7.41(2)(2) The delivery system shall be designed in a manner which does not disclose protected health information. Phar 7.41(3)(3) The delivery system shall maintain appropriate environmental controls, including temperature and humidity, to prevent drug adulteration. Phar 7.41(5)(5) A log shall be maintained by the dispensing pharmacy of all prescriptions delivered to the delivery system. Phar 7.41(6)(6) The delivery system shall be inventoried at least weekly and a list of unclaimed prescriptions shall be reviewed by a pharmacist. Phar 7.41(7)(7) The managing pharmacist shall establish written policies and procedures for all of the following: Phar 7.41 HistoryHistory: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21; correction in (1) made under s. 35.17, Stats., Register December 2020 No. 780. Phar 7.42Phar 7.42 Automated direct-to-patient dispensing system. Phar 7.42(1)(1) In this section “supervising practitioner” means the practitioner who is responsible for the operation of the automated direct-to-patient dispensing system and requirements of this section. Phar 7.42(2)(2) An automated direct-to-patient dispensing system in a secure and professionally appropriate environment in any of the locations under s. 450.062 (1) to (4), Stats., may operate for purposes of practitioner dispensing. The supervising practitioner will ensure all of the following requirements are met: Phar 7.42(2)(a)(a) Individuals with access to the automated direct-to-patient dispensing system for the purpose of stocking, inventory, and monitoring shall be limited to the supervising practitioner or a delegate. Phar 7.42(2)(b)(b) The automated direct-to-patient dispensing system shall label the prescription in compliance with s. Phar 7.05. Phar 7.42(2)(c)(c) The automated direct-to-patient dispensing system shall maintain records of all prescription fills and dispenses in compliance with s. Phar 7.11 (1). Phar 7.42(2)(d)(d) The reporting of all monitored prescription drugs dispensed from the automated direct-to-patient dispensing system to the prescription drug monitoring program. Phar 7.42(3)(3) The supervising practitioner or delegate shall establish written policies and procedures for automated direct-to-patient dispensing system for all of the following: Phar 7.42 HistoryHistory: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21; correction in (2) (intro.) made under s. 35.17, Stats., and correction in numbering of (3) (a) to (c) made under s. 13.92 (4) (b) 7., Stats., Register December 2020 No. 780. Phar 7.43(4)(a)(a) A remote dispensing location shall display a sign, easily viewable by customers, that states all of the following: Phar 7.43(4)(a)2.2. This remote dispensing location is being supervised by a pharmacist employed by: Phar 7.43(4)(a)3.3. Patient has a right to pharmacist consultation and information on how to file a complaint to the board. Phar 7.43(4)(b)(b) Remote dispensing may not occur if a pharmacist is not available remotely. Phar 7.43(4)(c)(c) A prescribed drug or device may not be dispensed in the absence of the ability of a patient and pharmacist’s delegate to communicate with a pharmacist. Phar 7.43(5)(5) Dispensing requirements. Remote dispensing shall comply with all of the following: Phar 7.43(5)(a)(a) Visually inspecting all prescription orders, labels and dispensed product. Phar 7.43(5)(b)(b) Labeling requirements under s. Phar 7.05. The prescription label shall contain the name and address of the remote dispensing site as the licensed facility from which the prescribed drug or device was dispensed. Phar 7.43(6)(6) Responsibilities of managing pharmacist. The managing pharmacist responsible for the remote dispensing pharmacy shall do all of the following: Phar 7.43(6)(a)(a) Have written policies and procedures for system operation, safety, security, accuracy and access. Phar 7.43(6)(b)(b) Implement an ongoing quality assurance program that monitors performance that includes the number of prescriptions dispensed per month, number of medication errors documented, loss or diversion, and documentation of remedial training to prevent future errors. Phar 7.43(6)(c)(c) Visit the remote dispensing location at least monthly to confirm delivery status of all drugs, to ensure written policies and procedures are being followed, and to ensure that remote dispensing personnel comply with all federal and state laws regulating the practice of pharmacy. Phar 7.43(6)(d)(d) Retain documentation of the visits at the remote dispensing location for a minimum of 5 years. Phar 7.43(6)(e)(e) Documentation indicating accepting responsibility for compliance with this section, signed and dated by the managing pharmacist. Phar 7.43(7)(7) Delegate requirements. A person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g), Stats., a pharmacy technician registered under s. 450.068, Stats., or a pharmacy graduate as defined in s. Phar 1.02 (10m) shall meet the following requirements to remote dispense: Phar 7.43(7)(c)(c) Have completed 1500 hours of work as a pharmacist delegate within the 3 years prior to engaging in remote dispensing or completed an accredited pharmacy technician training program. Phar 7.43 HistoryHistory: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21; correction in (2), (4) (a) 1. made under s. 35.17, Stats., Register December 2020 No. 780; EmR2213: emerg. r. (1), am. (2), (4) (b), (5) (b), (6) (title), (a) (intro.), 5., (b), eff. 11-1-22; CR 23-054: r. (1), am. (2), r. (3), am. (4) (a) 2. (intro.), (b), r. (4) (d), am. (5) (b), r. and recr. (6), am. (7) (intro.) Register August 2024 No. 824, eff. 9-1-24. Phar 7.50Phar 7.50 Definitions. In this subchapter: Phar 7.50(1)(1) “Chart order” means an order entered on the chart or a medical record of an inpatient or resident of an institutional facility by a practitioner or practitioner’s delegate for a drug product or device. Phar 7.50(2)(2) “Institutional facility” means a facility, as defined in s. 647.01 (4), Stats.; any hospital, nursing home, community-based residential facility, county home, county infirmary, county hospital, county mental health complex, or other place licensed or approved by the department of health services under s. 49.70, 49.71, 49.72, 50.03, 50.032, 50.033, 50.034, 50.35, 51.08, or 51.09, Stats.; a facility under s. 45.50, 51.05, 51.06, 146.903 (1) (b), 233.40, 233.41, 233.42, or 252.10, Stats.; a hospice facility under s. 50.90 (1) (c), Stats.; a county jail; and a correctional facility operated under the authority of the department of corrections. Phar 7.50(3)(3) “Institutional pharmacy” means a pharmacy that provides pharmacy services to an institutional facility. This definition is not for purposes under s. 450.09 (1) (a), Stats. Phar 7.50 HistoryHistory: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21. Phar 7.51Phar 7.51 Chart orders. A chart order shall contain all of the following:
/code/admin_code/phar/7
true
administrativecode
/code/admin_code/phar/7/iii/40/2/_1
Pharmacy Examining Board (Phar)
section
true
